Patents by Inventor Thorsten Wedel

Thorsten Wedel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pulverulent, directly compressible polyvinyl alcohol grades
    Patent number: 11040012
    Abstract: The present invention relates to premixes for the production of active compound-containing tablets which comprise polyvinyl alcohols (PVAs). The invention also relates to active compound-containing tablets which comprise a corresponding premix.
    Type: Grant
    Filed: July 3, 2015
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Roberto Ognibene, Finn Bauer, Thorsten Wedel, Guenter Moddelmog
  • Formulation having controlled, delayed release of active ingredient
    Patent number: 10874615
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: December 29, 2020
    Assignee: Merck Patent GmbH
    Inventors: Finn Bauer, Thorsten Wedel, Guenter Moddelmog, Gudrun Birk, Roberto Ognibene, Dieter Lubda
  • Directly compressible composition comprising microcrystalline cellulose
    Patent number: 10828258
    Abstract: The present invention relates to a directly compressible composition for the production of tablets which comprise fine-grained polyvinyl alcohols (PVAs) and fine-grained microcrystalline celluloses (MCCs) in a co-mixture. The present invention also relates to the use of this mixture and to a process for the preparation thereof.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: November 10, 2020
    Assignee: Merck Patent GmbH
    Inventors: Roberto Ognibene, Finn Bauer, Thorsten Wedel, Guenter Moddelmog
  • FORMULATION HAVING CONTROLLED, DELAYED RELEASE OF ACTIVE INGREDIENT
    Publication number: 20200246270
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Application
    Filed: April 21, 2020
    Publication date: August 6, 2020
    Applicant: Merck Patent GmbH
    Inventors: Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA
  • Directly compressible composition comprising microcrystalline cellulose
    Publication number: 20200214984
    Abstract: The present invention relates to a directly compressible composition for the production of tablets which comprise fine-grained polyvinyl alcohols (PVAs) and fine-grained microcrystalline celluloses (MCCs) in a co-mixture. The present invention also relates to the use of this mixture and to a process for the preparation thereof.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 9, 2020
    Applicant: Merck Patent GmbH
    Inventors: Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
  • DIRECTLY COMPRESSIBLE MATRIX FOR THE PRODUCTION OF TABLETS HAVING EXTENDED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
    Publication number: 20190307698
    Abstract: The present invention relates to tablets having extremely long release of active pharmaceutical ingredient, to the particular composition thereof and to the production thereof.
    Type: Application
    Filed: December 11, 2017
    Publication date: October 10, 2019
    Applicant: Merck Patent GmbH
    Inventors: Gudrun BIRK, Guenter MODDELMOG, Thorsten WEDEL
  • FORMULATION HAVING CONTROLLED, DELAYED RELEASE OF ACTIVE INGREDIENT
    Publication number: 20190038562
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Application
    Filed: August 25, 2016
    Publication date: February 7, 2019
    Applicant: Merck Patent GmbH
    Inventors: Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA
  • Directly compressible composition comprising microcrystalline cellulose
    Publication number: 20180318224
    Abstract: The present invention relates to a directly compressible composition for the production of tablets which comprise fine-grained polyvinyl alcohols (PVAs) and fine-grained microcrystalline celluloses (MCCs) in a co-mixture. The present invention also relates to the use of this mixture and to a process for the preparation thereof.
    Type: Application
    Filed: July 11, 2018
    Publication date: November 8, 2018
    Applicant: Merck Patent GmbH
    Inventors: Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
  • TABLETS HAVING MEDIA INDEPENDENT ACTIVE SUBSTANCE DELIVERY
    Publication number: 20180250233
    Abstract: The present invention relates to formulations having extended release of active ingredient, comprising an active ingredient from BCS Class I having high solubility and high permeability in a polyvinyl alcohol-containing matrix, from which the active ingredient is released at a controlled rate over a therapeutically relevant time period independently of the composition of the release medium.
    Type: Application
    Filed: August 25, 2016
    Publication date: September 6, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Finn BAUER, Thorsten WEDEL, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA, Guenter MODDELMOG
  • PULVERULENT, DIRECTLY COMPRESSIBLE POLYVINYL ALCOHOL GRADES
    Publication number: 20180207101
    Abstract: The present invention relates to premixes for the production of active compound-containing tablets which comprise polyvinyl alcohols (PVAs). The invention also relates to active compound-containing tablets which comprise a corresponding premix.
    Type: Application
    Filed: July 3, 2015
    Publication date: July 26, 2018
    Applicant: Merck Patent GmbH
    Inventors: Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
  • DIRECTLY COMPRESSIBLE POLYVINYL ALCOHOLS
    Publication number: 20170216213
    Abstract: The present invention relates to directly compressible co-mixtures for the production of tablets having delayed release of active compound which comprise polyvinyl alcohols (PVAs) and microcrystalline celluloses (MCCs).
    Type: Application
    Filed: July 3, 2015
    Publication date: August 3, 2017
    Applicant: Merck Patent GmbH
    Inventors: Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
  • Directly compressible composition comprising microcrystalline cellulose
    Publication number: 20170209380
    Abstract: The present invention relates to a directly compressible composition for the production of tablets which comprise fine-grained polyvinyl alcohols (PVAs) and fine-grained microcrystalline celluloses (MCCs) in a co-mixture. The present invention also relates to the use of this mixture and to a process for the preparation thereof.
    Type: Application
    Filed: July 3, 2015
    Publication date: July 27, 2017
    Applicant: Merck Patent GmbH
    Inventors: Roberto OGNIBENE, Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG
  • Anhydrous sodium carbonate having a low pore content
    Patent number: 9388053
    Abstract: The present invention relates to a highly pure, anhydrous sodium carbonate having a low pore content for use in pharmaceutical formulations and in the foods industry. Furthermore, a novel process for the preparation of this sodium carbonate is provided.
    Type: Grant
    Filed: November 10, 2012
    Date of Patent: July 12, 2016
    Assignee: Merck Patent GmbH
    Inventors: Jens Klatyk, Hans-Kurt Peth, Thorsten Wedel, Guenter Moddelmog
  • Magnesium hydroxide carbonate as excipient in pharmaceutical preparations having improved release of active ingredient
    Publication number: 20150328316
    Abstract: The present invention relates to pharmaceutical formulations of active ingredients which have low solubility in aqueous solutions, having improved release of active ingredient, and to a process for the preparation thereof. In particular, these are pharmaceutical preparations in which magnesium hydroxide carbonate serves as excipient.
    Type: Application
    Filed: November 22, 2013
    Publication date: November 19, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Guenter MODDELMOG, Roberto OGNIBENE, Thorsten WEDEL, Dieter LUBDA
  • MAGNESIUM HYDROXIDE CARBONATE AS CARRIER MATERIAL IN ACTIVE INGREDIENT-CONTAINING PREPARATIONS
    Publication number: 20150273062
    Abstract: The present invention relates to solid formulations which contain at least one porous carrier and one or more functional substances in a stable mixture, and to the use thereof.
    Type: Application
    Filed: August 19, 2013
    Publication date: October 1, 2015
    Applicant: Merck Patent GmbH
    Inventors: Guenter Moddelmog, Roberto Ognibene, Thorsten Wedel, Dieter Lubda
  • ANHYDROUS SODIUM CARBONATE HAVING A LOW PORE CONTENT
    Publication number: 20140336273
    Abstract: The present invention relates to a highly pure, anhydrous sodium carbonate having a low pore content for use in pharmaceutical formulations and in the foods industry. Furthermore, a novel process for the preparation of this sodium carbonate is provided.
    Type: Application
    Filed: November 10, 2012
    Publication date: November 13, 2014
    Applicant: Merck Patent GmbH
    Inventors: Jens Klatyk, Hans-Kurt Peth, Thorsten Wedel, Guenter Moddelmog
  • DIRECTLY COMPRESSIBLE MAGNESIUM HYDROXIDE CARBONATE
    Publication number: 20120301520
    Abstract: The present invention relates to a directly compressible magnesium hydroxide carbonate and to a process for the preparation thereof, and to the use thereof.
    Type: Application
    Filed: January 7, 2011
    Publication date: November 29, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Marianne Dohmen, Ralf Fielder, Heike Mueller, Jens Klatyk, Hans Kurt Peth, Guenter Moddelmog, Thorsten Wedel